South San Francisco-based Catalyst Biosciences, which has kept a low profile in recent years, has jumped back into the spotlight with a reverse merger with Targacept, the beleaguered North Carolina biotech that suffered a long string of embarrassing failures in the clinic.

…read more

Source: Pfizer partner Catalyst finds shortcut to Nasdaq in reverse merger with Targacept


0 No comments